Location History:
- Randolph, NJ (US) (2001)
- Cambridge, MA (US) (2014)
Company Filing History:
Years Active: 2001-2014
Title: Robert Edson Damon: Innovator in Pharmaceutical Chemistry
Introduction
Robert Edson Damon is an accomplished inventor based in Cambridge, MA, with a focus on advancements in pharmaceutical chemistry. With a total of 2 patents to his name, Damon has made significant contributions to the field through his innovative solutions.
Latest Patents
His most recent patents include "Bicyclic Acetyl-CoA Carboxylase Inhibitors and Uses Thereof," which outlines compounds of formula (I) along with their manufacturing methods and therapeutic applications. This invention details the potential of these compounds in combinations with other pharmacologically active agents and as part of pharmaceutical compositions. Additionally, he holds a patent for "Tetrahydroisoquinoline 3-Carboxamide Derivatives," which involves the exploration of specific chemical structures aimed at creating effective pharmaceutical therapies.
Career Highlights
Currently, Robert Edson Damon is associated with Novartis AG, a leading global healthcare company headquartered in Switzerland. His role in developing novel therapeutic compounds showcases his expertise in the pharmaceutical industry.
Collaborations
Damon has collaborated with prominent colleagues such as David Weninger Barnes and Gregory Raymond Bebernitz. These partnerships emphasize a strong network of innovators working together to advance pharmaceutical sciences and develop cutting-edge therapies.
Conclusion
Robert Edson Damon continues to push the boundaries of innovation in the pharmaceutical field. His contributions through patenting innovative compounds are valuable not only to his company but also to the healthcare industry at large. With ongoing work and collaborations, Damon remains a significant figure in the quest for new medical solutions.